Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Drops By 32.5%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) saw a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 15,400 shares, a decline of 32.5% from the October 31st total of 22,800 shares. Based on an average daily volume of 6,300 shares, the days-to-cover ratio is currently 2.4 days.

Cardio Diagnostics Price Performance

Shares of CDIOW remained flat at $0.03 during trading hours on Friday. The stock had a trading volume of 12 shares, compared to its average volume of 14,558. The firm has a fifty day moving average of $0.03 and a 200 day moving average of $0.04. Cardio Diagnostics has a one year low of $0.02 and a one year high of $0.28.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.